A novel SPINK5 donor splice site variant in a child with Netherton syndrome

Mol Genet Genomic Med. 2021 Mar;9(3):e1611. doi: 10.1002/mgg3.1611. Epub 2021 Feb 3.

Abstract

Background: Netherton syndrome (NS) is a genodermatosis caused by loss-of-function mutations in SPINK5, resulting in aberrant LEKTI expression.

Method: Next-generation sequencing of SPINK5 (NM_001127698.1) was carried out and functional studies were performed by immunofluorescence microscopy of a lesional skin biopsy using anti-LEKTI antibodies.

Results: We describe a novel SPINK5 likely pathogenic donor splice site variant (NM_001127698.1:c.2015+5G>A) in a patient with NS and confirm its functional significance by demonstrating complete loss of LEKTI expression in lesional skin by immunofluorescence analysis.

Conclusion: The 2015+5G>A is a novel, likely pathogenic variant in NS. Herein we review and assimilate documented SPINK5 pathogenic variants and discuss possible genotype-phenotype associations in NS.

Keywords: SPINK5; LEKTI; Netherton syndrome; Splice donor site pathogenic variant.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Humans
  • Male
  • Mutation
  • Netherton Syndrome / genetics*
  • Netherton Syndrome / pathology
  • Phenotype
  • RNA Splicing
  • Serine Peptidase Inhibitor Kazal-Type 5 / genetics*

Substances

  • SPINK5 protein, human
  • Serine Peptidase Inhibitor Kazal-Type 5